Dr. Yuval Cohen serves as the Chief Executive Officer of Corbus Pharmaceuticals, guiding the enterprise's corporate strategy, scientific research directions, and clinical execution. Having extensive executive leadership experience in the biotechnology sector, he oversees the advancement of the company's precision oncology and metabolic disease pipelines through rigorous human clinical trials.